Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines

European Respiratory Journal

Volumn 47, Issue 3, 2016, Pages 978-980

  Bartoli, Maria Laura ^a   Costa, Francesco ^a   Malagrinò, Laura ^a   Nieri, Dario ^a   Antonelli, Sandra ^a   Decusatis, Giovanna ^a   De Simone, Claudia ^a   Santerini, Sabrina ^a   Cianchetti, Silvana ^a   Latorre, Manuela ^a   Vagaggini, Barbara ^a   Paggiaro, Pierluigi ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; THEOPHYLLINE; BIOLOGICAL MARKER;

AGED; ANALYSIS OF VARIANCE; BLOOD GAS ANALYSIS; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLAMMATORY CELL; LETTER; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SPUTUM ANALYSIS; CLASSIFICATION; CYTOLOGY; EOSINOPHIL; MIDDLE AGED; NEUTROPHIL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPUTUM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 84959875201     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00784-2015     Document Type: Letter

References (13)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from www.goldcopd.org/uploads/users/files/GOLD-Report-2015-Apr2.pdf Date last updated: 2015. Date last accessed: Nov 11 2015.
2. Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in the COPDGene study: a prospective cohort study. Lancet Respir Med 2013; 1: 43-50.
3. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification. Am J Respir Crit Care Med 2012; 186: 975-981.
4. Soriano JB, Alfageme I, Almagro P, et al. Distribution and prognostic validity of the new GOLD grading classification. Chest 2013; 143: 694-702.
5. Agusti A, Edwards LD, Celli B, et al. Characteristics, stability and outcomes of the GOLD 2011 COPD groups in the ECLIPSE cohort. Eur Respir J 2013; 42: 637-647.
6. Cianchetti S, Bacci E, Bartoli ML, et al. Can hypertonic saline inhalation influence preformed chemokine and mediator release in induced sputum of chronic obstructive pulmonary disease patients? Comparison with isotonic saline. Clin Exp Allergy 2007; 37: 1819-1826.
7. Bartoli ML, Novelli F, Costa F, et al. Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm 2011; 2011: 891752.
8. Belda J, Leigh R, Parameswaran K, et al. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000; 161: 475-478.
9. Davidson WJ, The S, Leigh R. Establishing a normal range for induced sputum cell counts in Western Canada. Can Respir J 2013; 20: 424-425.
10. Langer D, Ciavaglia CE, Neder JA, et al. Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment. Expert Rev Respir Med 2014; 8: 731-749.
11. Singh D, Edwards L, Tal-Singer R, et al. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res 2010; 11: 77.
12. Saha S, Brightling CE. Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1: 39-47.
13. Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 356: 1480-1485.